Short description
Evozyne is a generative AI company that focuses on therapeutic discovery and drug development.
Description
Evozyne is a generative AI company that focuses on therapeutic discovery and drug development. It is a biotechnology company that specializes in protein design and molecular scale. Its mission is to unlock the potential of novel proteins to solve complex human and societal challenges by revolutionizing protein design.
It was founded in 2020 and is headquartered in Chicago, Illinois.
Last funding
Absolutely Noaccess
Sign in for full access
Total funding
$$2020202
Sign in for full access
Location
Chicago, Illinois, United States, North America
Founded on
January 1, 2020
Non-profit?
No
Acquired?
No
Employees count
51-100
Revenue range
$56378 - 90123
Sign in for full access
Investors
Noway Youcantaccess, Noaccess, No Way, Noaccess, No Way
Sign in for full access
Founders
Andrew Ferguson, Jeff Aronin, Rama Ranganathan